SCHEMBL8359592

SCHEMBL8359592

O=C1CCc2c1ccc1ccccc21

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.51
KDM4E B2RXH2 4/20 0.51
CYP1A2 P05177 3/20 0.51
CYP2C19 P33261 3/20 0.51
HSD17B10 Q99714 2/20 0.51
CYP2C9 P11712 2/20 0.51
GLA P06280 1/20 0.51
SIRT1 Q96EB6 1/20 0.51
ALDH1A1 P00352 5/20 0.46
HTT P42858 1/20 0.46
CDK5 Q00535 1/20 0.46
CDK5R1 Q15078 1/20 0.46
NCOA1 Q15788 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
DNMT1 P26358 1/20 0.44
CYP2A6 P11509 1/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PAX8 Q06710 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9576677 0.91 HPRT1 (0.50) HPGDKDM4ECYP1A2CYP2C19HSD17B10
SCHEMBL29862069 0.89 KDM4E (0.49) HPGDKDM4ECYP1A2CYP2C19HSD17B10
SCHEMBL9181184 0.89 KDM4E (0.49) HPGDKDM4ECYP1A2CYP2C19HSD17B10
SCHEMBL7413330 0.89 BRD4 (0.48) HPGDKDM4ECYP1A2CYP2C19HSD17B10
SCHEMBL8016638 0.82 MAOA (0.57) HPGDKDM4ECYP1A2CYP2C19HSD17B10
SCHEMBL16193431 0.81 BRD4 (0.48) HPGDKDM4ECYP1A2CYP2C19HSD17B10
SCHEMBL17264057 0.78 ALDH1A1 (0.48) HPGDKDM4EHSD17B10GLAALDH1A1
SCHEMBL15467504 0.76 CYP1A2 (0.46) HPGDKDM4ECYP1A2CYP2C19HSD17B10
SCHEMBL3346375 0.76 ALDH1A1 (0.51) HPGDKDM4ECYP1A2CYP2C19HSD17B10
SCHEMBL6705946 0.74 BCHE (0.45) HPGDKDM4ECYP1A2CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5861522-A Production of bridged metallocene complexes and intermediates therefor ALBEMARLE CORPORATION (US) 1999-01-19 US claimed
EP-0854876-A2 PRODUCTION OF BRIDGED METALLOCENE COMPLEXES AND INTERMEDIATES THEREFOR ALBEMARLE CORPORATION (US) 1998-07-29 EP claimed
US-5710299-A Production of bridged metallocene complexes and intermediates therefor ALBEMARLE CORPORATION (US) 1998-01-20 US claimed
WO-1997049712-A2 PRODUCTION OF BRIDGED METALLOCENE COMPLEXES AND INTERMEDIATES THEREFOR ALBEMARLE CORPORATION (US) 1997-12-31 WO claimed
EP-2053095-A2 Ink composition and inkjet recording method using the same Fujifilm Corporation (JP) 2009-04-29 EP disclosed
US-5861522-A Production of bridged metallocene complexes and intermediates therefor ALBEMARLE CORPORATION (US) 1999-01-19 US disclosed
EP-0854876-A2 PRODUCTION OF BRIDGED METALLOCENE COMPLEXES AND INTERMEDIATES THEREFOR ALBEMARLE CORPORATION (US) 1998-07-29 EP disclosed
US-5710299-A Production of bridged metallocene complexes and intermediates therefor ALBEMARLE CORPORATION (US) 1998-01-20 US disclosed
WO-1997049712-A2 PRODUCTION OF BRIDGED METALLOCENE COMPLEXES AND INTERMEDIATES THEREFOR ALBEMARLE CORPORATION (US) 1997-12-31 WO disclosed
US-5140047-A Antiinflammatory agents SMITHKLINE BEECHAM CORPORATION (US) 1992-08-18 US disclosed